Skip to main content
Equibles

Carol Lizak

CFO

Jaguar Health, Inc. (JAGX)

Chief Accounting Officer

Jaguar Health, Inc. (JAGX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Jaguar Health, Inc. publishes a filing, an earnings call transcript or a press release.

Get JAGX alerts

About Carol Lizak

Carol Lizak is recorded as CFO and Chief Accounting Officer at Jaguar Health, Inc. (JAGX). Carol Lizak has spoken on 18 earnings calls across 1 company, most recently for Jaguar Health, Inc. on August 19, 2026. Jaguar Health, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jaguar Health, Inc. includes Lisa A. Conte (CEO and Board Member), James J. Bochnowski (Chairman), Carol R. Lizak (CFO and Chief Accounting Officer) and 4 others.

Carol Lizak on recent calls

“I'll begin my review of our financials for the second quarter of 2026. License and grant revenue, as Lisa mentioned, Jaguar entered a U.S. commercial licensing agreement with FuturePAC in January 2026, and FuturePak is now the exclusive U.S. marketer for the company's Mitessi and Cantilevia CA1 products.”
CFO, Jaguar Health, Inc. Q2 FY2026 Earnings Call ·
“I'll begin my review of our financials for the first quarter of 2026. Louis, vitalizes the U.S. commercial rights for my TESI and Cantilevia CA1 in January 2026.”
CFO, Q1 FY2026 Earnings conference call (announced in 8-K) ·
“I'll begin my review of our financials for the second quarter of 2025.”
CFO, Jaguar Health, Inc. Q2 FY2025 Earnings Call ·
“I’ll begin my review of our financials for the first quarter of 2025.”
CFO, Jaguar Health, Inc. Q1 FY2025 Earnings Call ·
“I'll give my review of our financials for the third quarter of 2024.”
CFO, Jaguar Health, Inc. Q3 FY2024 Earnings Call ·

Affiliation history

Company network

Leadership on record at Jaguar Health, Inc.

Recent activity

Show 6 earlier activities